- Report
- February 2024
El Salvador
From €2233EUR$2,500USD£1,910GBP
- Report
- February 2024
South Africa
From €2233EUR$2,500USD£1,910GBP
- Report
- February 2024
Czech Republic
From €2233EUR$2,500USD£1,910GBP
From €2233EUR$2,500USD£1,910GBP
From €2233EUR$2,500USD£1,910GBP
- Report
- February 2024
Japan, United States, ... Japan, United States, Europe, Global
From €16526EUR$18,500USD£14,134GBP
- Report
- February 2024
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From €11166EUR$12,500USD£9,550GBP
- Report
- February 2024
Middle East
From €8486EUR$9,500USD£7,258GBP
- Report
- February 2024
Latin America
From €12953EUR$14,500USD£11,078GBP
- Report
- February 2024
Europe
From €17420EUR$19,500USD£14,898GBP
- Report
- February 2024
Asia Pacific
From €12953EUR$14,500USD£11,078GBP
- Report
- February 2024
Africa
From €5807EUR$6,500USD£4,966GBP
- Report
- February 2024
Global
From €25459EUR$28,500USD£21,773GBP
- Report
- November 2025
- 132 Pages
Global
From €849EUR$950USD£726GBP
- Report
- April 2024
- 132 Pages
Global
From €849EUR$950USD£726GBP
-
Journal - August 2026
- 66 Pages
Global
From €380EUR$425USD£325GBP
- Report
- September 2025
- 109 Pages
China, India, Russia, ... China, India, Russia, Brazil
From €5355EUR$5,995USD£4,580GBP
- Report
- June 2025
- 52 Pages
United States
From €4462EUR$4,995USD£3,816GBP
- Report
- June 2025
- 39 Pages
Mexico
From €4462EUR$4,995USD£3,816GBP
- Report
- June 2025
- 37 Pages
Brazil
From €4462EUR$4,995USD£3,816GBP

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more